Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study

Table 1

Clinical and demographic characteristics.

	Risperidone 𝑁=20	Olanzapine 𝑁=26	Quetiapine 𝑁=9	Ziprasidone 𝑁=13	Aripiprazole 𝑁=1	Unmedicated 𝑁=3	Total 𝑁=72
	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)
Age (years)	31.9 (13.4)	30.0 (8.8)	39.2 (12.7)	36.0 (16.6)	33.0	29.7 (4.7)	32.8 (12.3)
PANSS positive score	13.8 (3.6)	13.3 (4.4)	11.3 (3.9)	12.2 (3.7)	9.0	16.0 (6.1)	13.0 (4.1)
PANSS negative score	17.6 (6.7)	15.2 (6.6)	12.6 (5.3)	15.2 (5.9)	24.0	17.7 (7.6)	15.8 (6.5)
PANSS general score	28.2 (6.4)	24.7 (5.8)	23.7 (5.0)	25.2 (4.1)	32.0	28.0 (5.3)	25.9 (5.7)
PANSS total score	59.5 (13.5)	53.2 (13.2)	47.6 (12.5)	52.6 (10.4)	65.0	61.7 (18.8)	54.7 (13.2)
CDSS score	6.9 (4.8)	2.8 (3.4)	3.9 (3.9)	3.6 (3.7)	1.0	3.5 (2.1)	4.2 (4.2)*
GAF-F score	38.9 (8.7)	39.3 (7.9)	38.0 (5.5)	39.9 (7.7)	44.0	35.7 (4.0)	39.0 (7.6)
CGI-S score	4.0 (0.9)	3.5 (1.0)	3.0 (1.0)	3.7 (1.1)	4.0	4.0 (1.0)	3.63 (1.0)
Neurocogn. 𝑡-score	41.7 (8.0)	39.8 (7.7)	42.8 (5.8)	40.3 (8.3)	47.8	38.4 (-)	41.0 (7.5)
	𝑁 (%)	𝑁 (%)	𝑁 (%)	𝑁 (%)	𝑁 (%)	𝑁 (%)	𝑁 (%)
Ethnicity-whites	17 (85.0)	22 (84.6)	7 (77.8)	13 (100.0)	1 (100.0)	3 (100.0)	63 (87.5)
Drug naive	7 (35.0)	14 (53.8)	5 (55.6)	7 (53.8)	0	0	33 (45.8)
Illicit drug abuse^1	5 (25.0)	6 (23.1)	1 (11.1)	0	0	2 (66.7)	14 (19.4)
Alcohol abuse^1	2 (11.1)	2 (7.7)	1 (11.1)	1 (7.7)	0	0	6 (8.3)
Diagnoses
Drug-induced psychosis	3 (15.0)	2 (7.7)	0	1 (7.7)	0	1 (33.3)	7 (9.7)
Schizophrenia	10 (50.0)	16 (61.5)	5 (55.6)	7 (53.8)	1 (100.0)	1 (33.3)	40 (55.6)
Acute	1 (5.0)	3 (11.5)	1 (11.1)	0	0	1 (33.3)	6 (8.3)
Affective	4 (20.0)	3 (11.5)	1 (11.1)	3 (23.1)	0	0	11 (15.3)
Psychosis unspec.	0	2 (7.7)	1 (11.1)	0	0	0	3 (4.2)
Other/missing	2 (10.0)	0	1 (11.1)	2 (15.4)	0	0	5 (6.9)

Notes: 𝑁 = number of patients; SD = standard deviation (omitted in the aripiprazole group as only one patient); antipsychotic drug naïve = no life-time exposure to antipsychotic drugs before study inclusion; Schizophrenia = schizophrenia, schizo-affective disorder, acute polymorphic psychotic disorder with symptoms of schizophrenia, acute schizophrenia-like psychotic disorder, delusional disorder; Acute = acute psychosis other than those categorized under Schizophrenia; Affective = affective psychosis; Psychosis unspecified = miscellaneous psychotic disorders. All diagnoses are according to ICD-10; PANSS = the positive and Negative Syndrome Scale; CDSS = the Calgary Depression Scale for Schizophrenia; GAF-F = the Global Assessment of Functioning, split version, Functions scale; CGI = the Clinical Global Impression, severity of illness scale; Neurocogn. = sum 𝑡-score of the Repeatable Battery for the Assessment of Neuropsychological Status. ¹Last 6 months; *𝑃<0.05.